类风湿关节炎及类风湿关节炎相关间质性肺疾病患者的肺癌风险
这项回顾性匹配队列研究在退伍军人健康管理局(VA)2000至2019年间比较了类风湿关节炎(RA)及RA相关间质性肺疾病(RA-ILD)患者与无RA个体的肺癌风险。RA与肺癌风险升高独立相关(aHR 1.58),RA-ILD患者风险更高(aHR 3.25)。作者认为加强RA尤其RA-ILD的肺癌监测可能是有用策略。
要点
- RA患者肺癌风险较无RA个体升高(aHR 1.58,95%CI 1.52-1.64)。
- RA-ILD患者肺癌风险约为无RA个体的三倍(aHR 3.25,95%CI 2.13-4.95)。
- 从不吸烟者中RA仍与肺癌风险升高相关(aHR 1.65,95%CI 1.22-2.24)。
核心结论
- RA与肺癌风险升高超过50%相关,RA-ILD患者为尤其高风险群体,风险约升高三倍。
- 作者认为加强RA尤其RA-ILD的肺癌监测可能是有用策略,以减少这一主要癌症死亡原因带来的负担。
研究设计与样本
- 回顾性、匹配队列研究,在退伍军人健康管理局(VA)内于2000至2019年间进行。
- RA和RA-ILD通过经验证的行政数据算法识别,按年龄、性别和VA入组年份与无RA个体按最多1:10匹配。
- 肺癌从VA肿瘤数据库和国家死亡索引中识别,采用条件Cox回归模型校正种族、族裔、吸烟状态、橙剂暴露和合并症负担。
- 匹配了72,795例RA患者与633,937例无RA患者(平均年龄63岁;88%为男性)。
主要发现
- 在4,481,323患者年随访中,发生17,099例新发肺癌。
- RA与肺癌风险升高独立相关(aHR 1.58,95%CI 1.52-1.64)。
- 从不吸烟者中RA与肺癌风险升高相关(aHR 1.65,95%CI 1.22-2.24)。
- 新发RA患者中RA与肺癌风险升高相关(aHR 1.54,95%CI 1.44-1.65)。
- 与无RA对照相比,现患RA-ILD(n=757)与肺癌风险的关联(aHR 3.25,95%CI 2.13-4.95)强于无ILD的RA(aHR 1.57,95%CI 1.51-1.64)。
临床怎么用
- 作者认为加强RA尤其RA-ILD的肺癌监测可能是有用策略,以减少这一主要癌症死亡原因带来的负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to evaluate lung cancer risk in patients with rheumatoid arthritis (RA) and RA-interstitial lung disease (ILD). METHODS: We performed a retrospective, matched cohort study of RA and RA-ILD within the Veterans Health Administration (VA) between 2000 and 2019. Patients with RA and RA-ILD were identified with validated administrative-based algorithms, then matched (up to 1:10) on age, gender, and VA enrollment year to individuals without RA. Lung cancers were identified from a VA oncology database and the National Death Index. Conditional Cox regression models assessed lung cancer risk adjusting for race, ethnicity, smoking status, Agent Orange exposure, and comorbidity burden among matched individuals. Several sensitivity analyses were performed. RESULTS: We matched 72,795 patients with RA with 633,937 patients without RA (mean age 63 years; 88% male). Over 4,481,323 patient-years, 17,099 incident lung cancers occurred. RA was independently associated with an increased lung cancer risk (adjusted hazard ratio [aHR] 1.58 [95% confidence interval (CI) 1.52-1.64]), which persisted in never smokers (aHR 1.65 [95% CI 1.22-2.24]) and in those with incident RA (aHR 1.54 [95% CI 1.44-1.65]). Compared to non-RA controls, prevalent RA-ILD (n = 757) was more strongly associated with lung cancer risk (aHR 3.25 [95% CI 2.13-4.95]) than RA without ILD (aHR 1.57 [95% CI 1.51-1.64]). Analyses of both prevalent and incident RA-ILD produced similar results (RA-ILD vs non-RA aHR 2.88 [95% CI 2.45-3.40]). CONCLUSION: RA was associated with a >50% increased risk of lung cancer, and those with RA-ILD represented a particularly high-risk group with an approximate three-fold increased risk. Increased lung cancer surveillance in RA, and especially RA-ILD, may be a useful strategy for reducing the burden posed by the leading cause of cancer death.
引用
- Brooks RT, Luedders B, Wheeler A, et al. The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2024. PMID: 39073264. doi:10.1002/art.42961
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。